ET-traps Limited
ET-traps Limited is a pharmaceutical company that develops therapeutics targeting elevated endothelin-1 levels in the body. The company focuses on treatments for chronic kidney disease, cardiovascular diseases, and related disorders.
- Diabetes management solutions
- Pregnancy disorder treatments
- Therapies for cardiovascular diseases
- Treatment for neurodegenerative disorders
- Novel therapeutics for chronic kidney disease
Locations
Digital Popularity
Social Media
Competitors
AstraZeneca is a research-based bio-pharmaceutical company that focuses on the discovery, development, and commercialisation of innovative medicines.
Zetta Genomics is a pioneering company in the field of genomics, dedicated to empowering the application of genomic data to enhance health outcomes globally.
Protogenia Consulting Ltd offers pre-clinical and clinical development consultancy services to the pharmaceutical, biotech and cosmetic industries.
Company Details
ET-traps Limited is operated by Et-Traps Limited and is a Dormant company incorporated on 15 May 2015 with the registered office located in Cambridge, Cambridgeshire. Et-Traps Limited was registered 10 years ago.
Status
Dormant
Size
Micro
Directors
1
Age
10 years old
Employees
Unreported
Turnover
Unreported
Total Assets
Unreported
Cash in Bank
Unreported
Total Liabilities
-£65.32K